NASDAQ : IUS
-$0.14 (-0.2%)
| Source | Headline |
|---|---|
|
Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced the MIUD gurufocus.com - 2026-08-11 08:00:00 |